AI Signal & Stock Analysis · Avoid ↓
As of Aug 14 2026, 1:04 PM, AkshayaAI's signal for IDXX is Avoid ↓; the stock is at $553.24 (-2.42% today); neutral (RSI 44); technical trend is down-trend; news sentiment is positive.
Data as of Aug 14 2026, 1:04 PM. Informational analytics only — not investment advice.
| AI signal (Strength) | Avoid ↓ |
|---|---|
| Price | $553.24 |
| Change today | -2.42% |
| RSI (14) | 43.75 |
| Relative volume | 0.43 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $43.6B |
| Forward P/E | 33.00 |
| 52-week high | -28.1% away |
| 52-week low | +6.7% above |
| Technical trend | Down-trend (since 2024-01-26) |
| News sentiment | Positive |
| Sector | Healthcare-DiagResearch |
| Next earnings | 8/4/2026 8:30:00 AM |
As of Aug 14 2026, 1:04 PM, AkshayaAI assigns IDXX (Idexx Laboratories Inc) a Avoid signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
IDXX's RSI is neutral (RSI 44). A reading above 70 is typically considered overbought and below 30 oversold.
IDXX is trading about 28% below its 52-week high and 7% above its 52-week low as of Aug 14 2026, 1:04 PM.
IDXX's next earnings date is 8/4/2026 8:30:00 AM.
IDXX is classified under Healthcare-DiagResearch in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 1:04 PM and may not reflect real-time prices. Always do your own research.
Instant, data-backed answers — free to try.